Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Extended release formulations of rasagiline and uses thereof

Extended release formulations of rasagiline and uses thereof

US Patent 9943489 · Granted Apr 17, 2018

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Fixed dose combination of cannabinoids and medical mushrooms for prevention and 2025
Liquid crystalline dosage form for administering a statin2023
Compositions comprising thymoquinone and omega-3 fatty acids2022
Compositions comprising thymoquinone and omega-3 fatty acids2022
Synergistic combinations of caffeine, ginkgo biloba and beta-phenylethylamine2022
Synergistic combinations of caffeine, ginkgo biloba and beta-phenylethylamine2022
Stimulant abuse-deterrent compositions2021
Stimulant abuse-deterrent compositions2021
Extended release dosage forms of pregabalin2021
Compositions comprising melatonin2020
Compositions comprising melatonin2020
Sublingual delivery of glatiramer acetate2019